MIAMI, FL. AUGUST 13, 2018 -ArisGlobal, LLC, a leading provider of integrated cloud-based software solutions for life sciences, will present a session titled “Precision Pharmacovigilance: Is this the Way Forward?” at the upcoming World Drug Safety Congress Europe conference to be held in Amsterdam from September 10-11, 2018.
Dr. Vivek Ahuja, Vice President, Global Pharmacovigilance, ArisGlobal, will present the session, scheduled for September 10, 13:55-14:15 a.m., as part of the “Big Data & AI in Safety” track. As the sources of personal health data are increasing, and with big data coming from heterogeneous and complementing sources, Dr. Ahuja will discuss how there is now a distinct opportunity to understand the safety of drugs at a more granular level.
“Cutting edge technological advances in computing ability have empowered us to perform breakthrough research and analysis in the area of pharmacovigilance. ‘Big data’ of patients assimilated from various sources can be now stratified and segmented according to population demographics. We are now much closer to solving the mystery of how a deep understanding of this data can actually be used to prevent adverse events, thus attaining the real purpose of pharmacovigilance.“
ArisGlobal is a Silver Sponsor of the conference and an exhibitor and will be showcasing LifeSphere Safety, its cognitive computing platform, in Booth #7. Attendees are invited to meet with ArisGlobal staff to learn about its innovative and leading pharmacovigilance and safety platform.
Download ArisGlobal’s 2024 Industry Report 
